Regulation of myeloid cell proliferation and survival by p75/AIRM1 and CD33 surface receptors

Advances in Experimental Medicine and Biology

Volumn 495, Issue , 2001, Pages 55-61

  Mingari, Maria Cristina ^a   Vitale, Chiara ^a   Romagnani, Chiara ^a   Falco, Michela ^a   Moretta, Lorenzo ^a  

^a CENTRO DI BIOTECNOLOGIE AVANZATE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; PROTEIN P75; SIALOADHESIN;

APOPTOSIS; BONE MARROW CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CONFERENCE PAPER; HUMAN; HUMAN CELL; LEUKEMIA CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CROSS LINKING; REGULATORY MECHANISM;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; APOPTOSIS; BONE MARROW CELLS; CELL DIVISION; CELL SURVIVAL; CROSS-LINKING REAGENTS; HUMANS; KILLER CELLS, NATURAL; LEUKEMIA, MYELOID, CHRONIC; RECEPTORS, IMMUNOLOGIC;

EID: 0035699691     PISSN: 00652598     EISSN: None     Source Type: Journal    
DOI: 10.1007/978-1-4615-0685-0_8     Document Type: Article

References (32)

1. Biology of natural killer cells
2. In search of the "missing self". MHC molecules and NK cell recognition
3. Receptors for HLA-class I molecules in human Natural Killer cells
4. NK cell receptors
5. Regulation of immune responses through inhibitory receptors
6. Inhibitory pathways triggered by ITIM containing receptors
7. NKp46, a novel Natural Killer cell-specific surface molecule which mediates cell activation
8. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
9. Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
10. NKp44, a novel triggering surface molecule specifically expressed by activated Natural Killer cells is involved in non-MHC restricted tumor cell lysis
11. NKp44, a triggering receptor involved in tumor cell lysis by activated human Natural Killer cells, is a novel member of the immunoglobulin superfamily
12. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
13. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
14. 2B4 functions as a co-receptor in human natural killer cell activation
15. Natural cytotoxicity receptors that trigger human NK-mediated cytolysis
16. Identification of NKp80 a novel triggering molecule expressed by human natural killer cells
17. Cytolytic T lymphocytes displaying Natural Killer (NK)-like activity. Expression of NK-related functional receptors for HLA class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production
18. Human CD8+ T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations
19. Regulation of KIR expression in human T lymphocytes. A safety mechanism which may impair protective T cell responses
20. Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family which functions as an inhibitory receptor in human natural killer cells
21. p40, a novel surface molecule involved in the regulation of the non-MHC restricted cytolytic activity in humans
22. LAIR- 1, a novel inhibitory receptor expressed on human mononuclear leukocytes
23. Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human natural killer cells
24. Molecular cloning, expression, and chromosomal localization of a human gene encodong the CD33 myeloid differentiation antigen
25. Characterization of CD33 as a new member of the sialoadhesin family of cellular interaction molecules
26. Murine and humanized constructs of monoclonal antibody M195 (anti-CD33) for the therapy of acute myelogenous leukemia
27. The myeloid-specific sialic acid binding receptor, CD33, associates with the protein-tyrosine phosphatases SHP-1, SHP-2
28. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor
29. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2
30. Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells
31. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias. Engagement of CD33 induces apoptosis of leukemic cells
32. Engagement of CD33 surface molecules prevents the generation of dendritic cells from both monocytes and CD34+ myeloid precursors